Anti-retinal pigment epithelium antibodies in acute exudative polymorphous vitelliform maculopathy: A new hypothesis about disease pathogenesis

Archives of Ophthalmology

Volumn 129, Issue 1, 2011, Pages 23-29

  Koreen, Larry ^a,b   He, Shirley X ^a   Johnson, Mark W ^a   Hackel, Richard E ^a   Khan, Naheed W ^a   Heckenlively, John R ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b DUKE UNIVERSITY EYE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPIGMENT EPITHELIUM ANTIBODY; AUTOANTIBODY; PEROXIREDOXIN 3; UNCLASSIFIED DRUG;

ACUTE EXUDATIVE POLYMORPHOUS VITELLIFORM MACULOPATHY; ADULT; ANAMNESIS; ANTIBODY BLOOD LEVEL; ARTICLE; AUTOIMMUNE DISEASE; CANCER REGRESSION; CANCER STAGING; CASE REPORT; CELL CULTURE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; EYE EXAMINATION; HUMAN; MALE; MASS SPECTROMETRY; MELANOMA; METASTASIS; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN ANALYSIS; RETINA MACULOPATHY; SUBRETINAL FLUID; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

ACUTE DISEASE; ANTINEOPLASTIC AGENTS, ALKYLATING; AUTOANTIBODIES; AUTOANTIGENS; BLOTTING, WESTERN; CELLS, CULTURED; DACARBAZINE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ELECTRORETINOGRAPHY; EXUDATES AND TRANSUDATES; FLUORESCEIN ANGIOGRAPHY; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MASS SPECTROMETRY; MELANOMA; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; PARANEOPLASTIC SYNDROMES; PEROXIREDOXINS; RETINAL PIGMENT EPITHELIUM; TOMOGRAPHY, OPTICAL COHERENCE; VITELLIFORM MACULAR DYSTROPHY;

EID: 78651295929     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2010.316     Document Type: Article

References (26)

1. Chan CK, Gass JD, Lin SG. Acute exudative polymorphous vitelliform maculopathy syndrome. Retina. 2003;23(4):453-462.
2. Gass JD, Chuang EL, Granek H. Acute exudative polymorphous vitelliform maculopathy. Trans Am Ophthalmol Soc. 1988;86:354-366.
3. Vaclavik V, Ooi KG, Bird AC, Robson AG, Holder GE, Webster AR. Autofluorescence findings in acute exudative polymorphous vitelliform maculopathy. Arch Ophthalmol. 2007;125(2):274-277.
4. Cruz-Villegas V, Villate N, Knighton RW, Rubsamen P, Davis JL. Optical coherence tomographic findings in acute exudative polymorphous vitelliform maculopathy. Am J Ophthalmol. 2003;136(4):760-763.
5. Vianna RN, Muralha A, Muralha L. Indocyanine-green angiography in acute idiopathic exudative polymorphous vitelliform maculopathy. Retina. 2003;23(4):538-541.
6. Spaide R. Autofluorescence from the outer retina and subretinal space: hypothesis and review. Retina. 2008;28(1):5-35.
7. Kozma P, Locke KG, Wang YZ, Birch DG, Edwards AO. Persistent cone dysfunction in acute exudative polymorphous vitelliform maculopathy. Retina. 2007;27(1):109-113.
8. Eksandh L, Adamus G, Mosgrove L, Andréasson S. Autoantibodies against bestrophin in a patient with vitelliform paraneoplastic retinopathy and a metastatic choroidal malignant melanoma. Arch Ophthalmol. 2008;126(3):432-435.
9. Watabe S, Hiroi T, Yamamoto Y, et al. SP-22 is a thioredoxin-dependent peroxide reductase in mitochondria. Eur J Biochem. 1997;249(1):52-60.
10. Cao Z, Lindsay JG, Isaacs NW. Mitochondrial peroxiredoxins. Subcell Biochem. 2007;44:295-315.
11. Decanini A, Nordgaard CL, Feng X, Ferrington DA, Olsen TW. Changes in select redox proteins of the retinal pigment epithelium in age-related macular degeneration. Am J Ophthalmol. 2007;143(4):607-615.
12. West KA, Yan L, Shadrach K, et al. Protein database, human retinal pigment epithelium. Mol Cell Proteomics. 2003;2(1):37-49.
13. Sotodeh M, Paridaens D, Keunen J, van Schooneveld M, Adamus G, Baarsma S. Paraneoplastic vitelliform retinopathy associated with cutaneous or uveal melanoma and metastases. Klin Monbl Augenheilkd. 2005;222(11):910-914.
14. Lu Y, Jia L, He S, et al. Melanoma-associated retinopathy: a paraneoplastic autoimmune complication. Arch Ophthalmol. 2009;127(12):1572-1580.
15. Borkowski LM, Grover S, Fishman GA, Jampol LM. Retinal findings in melanoma-associated retinopathy. Am J Ophthalmol. 2001;132(2):273-275.
16. Jampol LM, Kim HH, Bryar PJ, Shankle JB, Lee RT, Johnston RL. Multiple serous retinal detachments and subretinal deposits as the presenting signs of metastatic melanoma. Retina. 2004;24(2):320-322.
17. Nieuwendijk TJ, Hooymans JM. Paraneoplastic vitelliform retinopathy associated with metastatic choroidal melanoma. Eye (Lond). 2007;21(11):1436- 1437.
18. Palmowski AM, Haus AH, Pföhler C, et al. Bilateral multifocal chorioretinopathy in a woman with cutaneous malignant melanoma. Arch Ophthalmol. 2002;120(12):1756-1761.
19. Zacks DN, Pinnolis MK, Berson EL, Gragoudas ES. Melanoma-associated retinopathy and recurrent exudative retinal detachments in a patient with choroidal melanoma. Am J Ophthalmol. 2001;132(4):578-581.
20. Hooks JJ, Percopo C, Wang Y, Detrick B. Retina and retinal pigment epithelial cell autoantibodies are produced during murine coronavirus retinopathy. J Immunol. 1993;151(6):3381-3389.
21. Wang Y, Burnier M, Detrick B, Hooks JJ. Genetic predisposition to coronavirus-induced retinal disease. Invest Ophthalmol Vis Sci. 1996;37(1):250-254.
22. Karasawa R, Ozaki S, Nishioka K, Kato T. Autoantibodies to peroxiredoxin I and IV in patients with systemic autoimmune diseases. Microbiol Immunol. 2005;49(1):57-65.
23. Alge CS, Hauck SM, Priglinger SG, Kampik A, Ueffing M. Differential protein profiling of primary versus immortalized human RPE cells identifies expression patterns associated with cytoskeletal remodeling and cell survival. J Proteome Res. 2006;5(4):862-878.
24. Moreira EF, Kantorow M, Rodriguez IR. Peroxiredoxin 3 (PDRX3) is highly expressed in the primate retina especially in blue cones. Exp Eye Res. 2008;86(2):452-455.
25. Forooghian F, Macdonald IM, Heckenlively JR, et al. The need for standardization of antiretinal antibody detection and measurement. Am J Ophthalmol. 2008;146(4):489-495.
26. Alge CS, Suppmann S, Priglinger SG, et al. Comparative proteome analysis of native differentiated and cultured dedifferentiated human RPE cells. Invest Ophthalmol Vis Sci. 2003;44(8):3629-3641.